324 related articles for article (PubMed ID: 17376623)
1. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
[TBL] [Abstract][Full Text] [Related]
2. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
Plank TL; Logginidou H; Klein-Szanto A; Henske EP
Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
[TBL] [Abstract][Full Text] [Related]
3. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
[TBL] [Abstract][Full Text] [Related]
4. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
[TBL] [Abstract][Full Text] [Related]
5. Hamartin and tuberin expression in human tissues.
Johnson MW; Kerfoot C; Bushnell T; Li M; Vinters HV
Mod Pathol; 2001 Mar; 14(3):202-10. PubMed ID: 11266527
[TBL] [Abstract][Full Text] [Related]
6. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
[TBL] [Abstract][Full Text] [Related]
7. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
[TBL] [Abstract][Full Text] [Related]
9. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles.
Plank TL; Yeung RS; Henske EP
Cancer Res; 1998 Nov; 58(21):4766-70. PubMed ID: 9809973
[TBL] [Abstract][Full Text] [Related]
10. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Astrinidis A; Henske EP
Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
[TBL] [Abstract][Full Text] [Related]
11. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
12. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
Rosner M; Freilinger A; Lubec G; Hengstschläger M
Int J Oncol; 2005 Nov; 27(5):1411-24. PubMed ID: 16211238
[TBL] [Abstract][Full Text] [Related]
13. Tuberin activates the proapoptotic molecule BAD.
Freilinger A; Rosner M; Krupitza G; Nishino M; Lubec G; Korsmeyer SJ; Hengstschläger M
Oncogene; 2006 Oct; 25(49):6467-79. PubMed ID: 16702951
[TBL] [Abstract][Full Text] [Related]
14. Proteins interacting with the tuberous sclerosis gene products.
Rosner M; Freilinger A; Hengstschläger M
Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
[TBL] [Abstract][Full Text] [Related]
16. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
Rosner M; Freilinger A; Hengstschläger M
Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Tavazoie SF; Alvarez VA; Ridenour DA; Kwiatkowski DJ; Sabatini BL
Nat Neurosci; 2005 Dec; 8(12):1727-34. PubMed ID: 16286931
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
[TBL] [Abstract][Full Text] [Related]
19. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]